DekaBank Deutsche Girozentrale’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-261,130
| Closed | -$47.8M | – | 1449 |
|
|
2021
Q2 | $47.8M | Sell |
261,130
-1,438
| -0.5% | -$247K | 0.14% | 165 |
|
|
2021
Q1 | $40.2M | Buy |
262,568
+34,621
| +15% | +$5.36M | 0.13% | 169 |
|
|
2020
Q4 | $35.7M | Buy |
227,947
+94,906
| +71% | +$12.2M | 0.13% | 162 |
|
|
2020
Q3 | $14.8M | Buy |
133,041
+86,434
| +185% | +$9.32M | 0.07% | 236 |
|
|
2020
Q2 | $5.15M | Sell |
46,607
-1,401
| -3% | -$149K | 0.03% | 308 |
|
|
2020
Q1 | $4.22M | Buy |
48,008
+2,656
| +6% | +$261K | 0.03% | 303 |
|
|
2019
Q4 | $4.9M | Sell |
45,352
-90,960
| -67% | -$9.73M | 0.03% | 338 |
|
|
2019
Q3 | $13.4M | Sell |
136,312
-29,617
| -18% | -$3.34M | 0.08% | 216 |
|
|
2019
Q2 | $21.1M | Buy |
165,929
+105,961
| +177% | +$13.7M | 0.11% | 216 |
|
|
2019
Q1 | $7.47M | Sell |
59,968
-77,235
| -56% | -$9.6M | 0.04% | 360 |
|
|
2018
Q4 | $13.5M | Buy |
137,203
+77,235
| +129% | +$9.13M | 0.09% | 223 |
|
|
2018
Q3 | $7.47M | Sell |
59,968
-4,877
| -8% | -$612K | 0.04% | 363 |
|
|
2018
Q2 | $8.01M | Sell |
64,845
-57,058
| -47% | -$6.67M | 0.05% | 333 |
|
|
2018
Q1 | $13.6M | Buy |
121,903
+9,105
| +8% | +$1.09M | 0.09% | 231 |
|
|
2017
Q4 | $15.5M | Hold |
112,798
| – | – | 0.12% | 181 |
|
|
2017
Q3 | $15.5M | Sell |
112,798
-1,252
| -1% | -$170K | 0.12% | 181 |
|
|
2017
Q2 | $14.1M | Sell |
114,050
-443
| -0.4% | -$51.6K | 0.11% | 200 |
|
|
2017
Q1 | $14M | Buy |
114,493
+17,642
| +18% | +$2.27M | 0.13% | 171 |
|
|
2016
Q4 | $12M | Sell |
96,851
-15,828
| -14% | -$1.94M | 0.13% | 171 |
|
|
2016
Q3 | $13.5M | Buy |
112,679
+13,097
| +13% | +$1.69M | 0.15% | 160 |
|
|
2016
Q2 | $11.4M | Sell |
99,582
-3,790
| -4% | -$538K | 0.13% | 184 |
|
|
2016
Q1 | $14M | Sell |
103,372
-8,446
| -8% | -$1.24M | 0.17% | 135 |
|
|
2015
Q4 | $21.4M | Sell |
111,818
-20,511
| -16% | -$3.58M | 0.25% | 91 |
|
|
2015
Q3 | $19.9M | Buy |
132,329
+35,815
| +37% | +$6.53M | 0.24% | 85 |
|
|
2015
Q2 | $17.4M | Sell |
96,514
-9
| -0% | -$1.55K | 0.21% | 100 |
|
|
2015
Q1 | $17.4M | Buy |
96,523
+9,810
| +11% | +$1.78M | 0.22% | 101 |
|
|
2014
Q4 | $16.3M | Sell |
86,713
-3,670
| -4% | -$680K | 0.2% | 111 |
|
|
2014
Q3 | $15.2M | Sell |
90,383
-34,989
| -28% | -$5.75M | 0.21% | 109 |
|
|
2014
Q2 | $19.8M | Buy |
125,372
+31,592
| +34% | +$4.99M | 0.3% | 80 |
|
|
2014
Q1 | $14.1M | Sell |
93,780
-1,998
| -2% | -$318K | 0.22% | 100 |
|
|
2013
Q4 | $12.6M | Sell |
95,778
-4,850
| -5% | -$582K | 0.21% | 100 |
|
|
2013
Q3 | $11.6M | Buy |
100,628
+3,124
| +3% | +$343K | 0.2% | 99 |
|
|
2013
Q2 | $9.08M | Buy |
+97,504
| New | +$9.4M | 0.18% | 109 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM